{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:07:16Z","timestamp":1794413236828,"version":"4.9.1"},"reference-count":200,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010311","name":"Guts UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008538","name":"PSC Partners Seeking a Cure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012357","name":"LifeArc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","gastrojournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1053\/j.gastro.2024.01.049","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T21:42:36Z","timestamp":1707514956000},"page":"995-1019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts"],"prefix":"10.1053","volume":"166","author":[{"given":"Palak J.","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon M.","family":"Hirschfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Vierling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2024.01.049_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib2","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/liv.14645","article-title":"Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis","volume":"40","author":"Culver","year":"2020","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2024.01.049_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1155\/2010\/431913","article-title":"Autoantibodies and liver disease: uses and abuses","volume":"24","author":"Zeman","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.01.049_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1053\/j.gastro.2024.01.049_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ajg.2012.363","article-title":"Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis","volume":"108","author":"Nanda","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.01.049_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","article-title":"Environmental triggers in IBD: a review of progress and evidence","volume":"15","author":"Ananthakrishnan","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102459","article-title":"Interaction between food antigens and the immune system: association with autoimmune disorders","volume":"19","author":"Vojdani","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.gastro.2024.01.049_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-022-05380-y","article-title":"Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation","volume":"611","author":"Arifuzzaman","year":"2022","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2021.02.003","article-title":"Cytoplasmic DNA sensing by KU complex in aged CD4+ T cell potentiates T cell activation and aging-related autoimmune inflammation","volume":"54","author":"Wang","year":"2021","journal-title":"Immunity"},{"key":"10.1053\/j.gastro.2024.01.049_bib11","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep4.1582","article-title":"Exploratory study of autoantibody profiling in drug-induced liver injury with an autoimmune phenotype","volume":"4","author":"Lammert","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2024.01.049_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41586-022-05645-6","article-title":"Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS","volume":"614","author":"Pallett","year":"2023","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","article-title":"Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations","volume":"127","author":"Sood","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.01.049_bib14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/gut.36.6.927","article-title":"Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group","volume":"36","author":"Watson","year":"1995","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib15","article-title":"Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis","volume":"3","author":"Dyson","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1053\/j.gastro.2024.01.049_bib16","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","article-title":"Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies","volume":"20","author":"Trivedi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2011.03.031","article-title":"Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.13154","article-title":"A\u00a0comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease","volume":"41","author":"Eaton","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.01.049_bib21","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41467-023-36678-8","article-title":"Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis","volume":"14","author":"Han","year":"2023","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2024.01.049_bib22","doi-asserted-by":"crossref","first-page":"46273","DOI":"10.18632\/oncotarget.10090","article-title":"National incidence of autoimmune liver diseases and its relationship with the human development index","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1053\/j.gastro.2024.01.049_bib23","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.cgh.2021.01.029","article-title":"The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude","volume":"19","author":"Webb","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib24","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000357","article-title":"Identification of a latitude gradient in the prevalence of primary biliary cholangitis","volume":"12","author":"French","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2024.01.049_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis","volume":"35","author":"Vogel","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jhep.2009.01.015","article-title":"Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations","volume":"50","author":"Tanaka","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.32172","article-title":"E.\u00a0coli and the etiology of human PBC: antimitochondrial antibodies and spreading determinants","volume":"75","author":"Yang","year":"2022","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clinre.2011.07.013","article-title":"Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside","volume":"36","author":"Smyk","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1053\/j.gastro.2024.01.049_bib29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/cei.12224","article-title":"Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10\/Idd18) mice","volume":"175","author":"Wang","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib30","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib31","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.32582","article-title":"Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease","volume":"76","author":"Hartl","year":"2022","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib32","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.32572","article-title":"Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome","volume":"76","author":"Efe","year":"2022","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2022.09.010","article-title":"Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury","volume":"78","author":"Chalasani","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.06.013","article-title":"Mucosal immunity in liver autoimmunity: a comprehensive review","volume":"46","author":"Trivedi","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MOG.0000000000000809","article-title":"Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again","volume":"38","author":"Liaskou","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2024.01.049_bib36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abk2189","article-title":"Immune-microbe interactions early in life: a determinant of health and disease long term","volume":"376","author":"Brodin","year":"2022","journal-title":"Science"},{"key":"10.1053\/j.gastro.2024.01.049_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41586-021-03531-1","article-title":"Thymic development of gut-microbiota-specific T cells","volume":"594","author":"Zegarra-Ruiz","year":"2021","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib38","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.1038\/s41467-022-35126-3","article-title":"A\u00a0conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and mice","volume":"13","author":"Hackstein","year":"2022","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2024.01.049_bib39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41586-022-04916-6","article-title":"Immune tolerance of food is mediated by layers of CD4+ T cell dysfunction","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib40","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41586-022-05141-x","article-title":"ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut","volume":"610","author":"Lyu","year":"2022","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41586-022-05089-y","article-title":"A\u00a0ROR\u03b3t+ cell instructs gut microbiota-specific Treg cell differentiation","volume":"610","author":"Kedmi","year":"2022","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib42","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41586-022-05309-5","article-title":"Novel antigen presenting cell imparts Treg-dependent tolerance to gut microbiota","volume":"610","author":"Akagbosu","year":"2022","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib43","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-022-04567-7","article-title":"Environmental factors shaping the gut microbiome in a Dutch population","volume":"604","author":"Gacesa","year":"2022","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib44","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04949-x","article-title":"Within-host evolution of a gut pathobiont facilitates liver translocation","volume":"607","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib45","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ecco-jcc\/jjaa021","article-title":"A\u00a0pilot integrative analysis of colonic gene expression, gut microbiota, and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways","volume":"14","author":"Quraishi","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2024.01.049_bib46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC\u2013IBD is distinct to that of IBD","volume":"66","author":"Quraishi","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib47","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2020.12.058","article-title":"Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis","volume":"160","author":"Kummen","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.01.049_bib48","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.01.049_bib49","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1053\/j.gastro.2024.01.049_bib50","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"key":"10.1053\/j.gastro.2024.01.049_bib51","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/gutjnl-2018-316670","article-title":"Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis","volume":"68","author":"Liao","year":"2019","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gutjnl-2021-326500","article-title":"Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC","volume":"72","author":"Awoniyi","year":"2023","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib54","doi-asserted-by":"crossref","first-page":"eaax2220","DOI":"10.1126\/scitranslmed.aax2220","article-title":"Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice","volume":"12","author":"Choi","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.gastro.2024.01.049_bib55","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib56","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.chom.2022.05.006","article-title":"Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis","volume":"30","author":"Pandey","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1053\/j.gastro.2024.01.049_bib57","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib58","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fcimb.2020.00342","article-title":"Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals","volume":"10","author":"Lou","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1053\/j.gastro.2024.01.049_bib59","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.01.049_bib60","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/apt.15754","article-title":"A\u00a0disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis","volume":"51","author":"Liwinski","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.01.049_bib61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","article-title":"Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis","volume":"69","author":"Lemoinne","year":"2020","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib62","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/gutjnl-2019-320008","article-title":"Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species","volume":"69","author":"R\u00fchlemann","year":"2020","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib63","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis","volume":"56","author":"Banales","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jhep.2022.07.034","article-title":"Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes","volume":"78","author":"Kennedy","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A\u00a0biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1034\/j.1600-0676.2001.021004247.x","article-title":"Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis","volume":"21","author":"Oswald","year":"2002","journal-title":"Liver"},{"key":"10.1053\/j.gastro.2024.01.049_bib67","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2021.10.009","article-title":"Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection","volume":"76","author":"Herta","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib68","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/jhep.2001.22646","article-title":"Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases","volume":"33","author":"Zollner","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Schaap","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib70","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1053\/j.gastro.2024.01.049_bib71","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","article-title":"Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis","volume":"142","author":"Modica","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.01.049_bib72","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1172\/JCI18945","article-title":"Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis","volume":"112","author":"Liu","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2024.01.049_bib73","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.4049\/jimmunol.0901347","article-title":"The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis","volume":"183","author":"Mencarelli","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2306185","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis","volume":"390","author":"Kowdley","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2024.01.049_bib75","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/HEP.0000000000000395","article-title":"Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study","volume":"78","author":"Hirschfield","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib76","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2312100","article-title":"A\u00a0phase 3 trial of seladelpar in primary biliary cholangitis","volume":"390","author":"Hirschfield","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2024.01.049_bib77","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1053\/j.gastro.2022.08.054","article-title":"Greater transplant-free survival in patients receiving obeticholic acid for primary biliary cholangitis in a clinical trial setting compared to real-world external controls","volume":"163","author":"Murillo Perez","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.01.049_bib78","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jhep.2021.04.010","article-title":"Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis","volume":"75","author":"Tanaka","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib79","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","article-title":"Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling","volume":"3","author":"Schneider","year":"2021","journal-title":"Nat Metab"},{"key":"10.1053\/j.gastro.2024.01.049_bib80","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jhep.2016.09.020","article-title":"The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation","volume":"66","author":"Schrumpf","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib81","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A\u00a0metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib82","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","article-title":"Human gut bacteria produce TH17-modulating bile acid metabolites","volume":"603","author":"Paik","year":"2022","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib83","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3+ regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib84","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib86","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","article-title":"Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians","volume":"599","author":"Sato","year":"2021","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2024.01.049_bib87","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fimmu.2019.00426","article-title":"Microbiome dependent regulation of Tregs and Th17 cells in mucosa","volume":"10","author":"Pandiyan","year":"2019","journal-title":"Front Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102719","article-title":"Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid X receptor","volume":"54","author":"Gadaleta","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1053\/j.gastro.2024.01.049_bib89","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb0036","article-title":"A\u00a0heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis","volume":"13","author":"Jiang","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.gastro.2024.01.049_bib90","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jhep.2016.01.017","article-title":"Single-gene association between GATA-2 and autoimmune hepatitis: a novel genetic insight highlighting immunologic pathways to disease","volume":"64","author":"Webb","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib91","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib92","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhep.2018.05.035","article-title":"Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study","volume":"69","author":"Gr\u00f8nb\u00e6k","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib93","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ng.2395","article-title":"Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis","volume":"44","author":"Liu","year":"2012","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2024.01.049_bib94","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2024.01.049_bib95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00281-022-00950-8","article-title":"How genetic risk contributes to autoimmune liver disease","volume":"44","author":"Ellinghaus","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1053\/j.gastro.2024.01.049_bib96","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.31893","article-title":"HLA profile predicts severity of autoimmune liver disease in children of European ancestry","volume":"74","author":"Ma","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975115","article-title":"New insights on the role of human leukocyte antigen complex in primary biliary cholangitis","volume":"13","author":"Mulinacci","year":"2022","journal-title":"Front Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib98","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.01.049_bib99","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.32417","article-title":"Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1","volume":"76","author":"Li","year":"2022","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib100","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/lt.22161","article-title":"Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations","volume":"16","author":"Bowlus","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2024.01.049_bib101","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.3528","article-title":"Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2024.01.049_bib102","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs","volume":"75","author":"Cordell","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib103","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2024.01.049_bib104","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2024.01.049_bib105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12016-014-8423-1","article-title":"Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn\u2019s disease\u2014a comprehensive review","volume":"48","author":"Maroni","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib106","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1073\/pnas.1322731111","article-title":"Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis","volume":"111","author":"Nakagawa","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2024.01.049_bib107","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26447","article-title":"Increased Th17 response to pathogen stimulation in patients with primary sclerosing cholangitis","volume":"58","author":"Katt","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib108","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2013.07.003","article-title":"The role of natural killer cells in autoimmune liver disease: a comprehensive review","volume":"46","author":"Hudspeth","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib110","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2013.12.027","article-title":"Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms","volume":"60","author":"Sebode","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib111","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","article-title":"Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population","volume":"156","author":"Rong","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.02.009","article-title":"Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2R\u03b1(-\/-) mice","volume":"51","author":"Yao","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib113","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035307","article-title":"Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population","volume":"7","author":"Gaj","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2024.01.049_bib115","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.cgh.2023.01.014","article-title":"Evaluation of tofacitinib in primary sclerosing cholangitis and associated colitis: a multicenter, retrospective study","volume":"21","author":"Schregel","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib116","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","article-title":"Frequency of monosomy X in women with primary biliary cirrhosis","volume":"363","author":"Invernizzi","year":"2004","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2024.01.049_bib117","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.21696","article-title":"Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis","volume":"46","author":"Miozzo","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib118","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaut.2012.12.008","article-title":"Y\u00a0chromosome loss in male patients with primary biliary cirrhosis","volume":"41","author":"Lleo","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib119","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1053\/j.gastro.2021.02.061","article-title":"X\u00a0chromosome contribution to the genetic architecture of primary biliary cholangitis","volume":"160","author":"Asselta","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.01.049_bib120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13148-015-0098-9","article-title":"DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis","volume":"7","author":"Lleo","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1053\/j.gastro.2024.01.049_bib121","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2005.08.009","article-title":"Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives","volume":"25","author":"Chuang","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib122","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/j.gastro.2023.03.235","article-title":"The epigenetic reader, BRD2, mediates cholangiocyte senescence via interaction with ETS1","volume":"165","author":"Kang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.01.049_bib123","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/j.gastro.2020.10.008","article-title":"Epigenomic evaluation of cholangiocyte transforming growth factor-\u03b2 signaling identifies a selective role for histone 3 lysine 9 acetylation in biliary fibrosis","volume":"160","author":"Aseem","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.01.049_bib124","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12072-012-9362-7","article-title":"Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments","volume":"7","author":"Trivedi","year":"2013","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2024.01.049_bib125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cei.13198","article-title":"Pathogen infections and primary biliary cholangitis","volume":"195","author":"Tanaka","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib126","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.21828","article-title":"Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis","volume":"46","author":"Leung","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib127","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaut.2006.11.004","article-title":"T\u00a0cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis","volume":"27","author":"Allina","year":"2006","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib128","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gutjnl-2016-311739","article-title":"Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis","volume":"66","author":"Jendrek","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib131","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/hep.28116","article-title":"High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires","volume":"63","author":"Liaskou","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib132","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhep.2016.09.002","article-title":"Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease","volume":"66","author":"Henriksen","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib133","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2024.01.049_bib134","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jhep.2014.02.011","article-title":"Influence of CD8 T cell priming in liver and gut on the enterohepatic circulation","volume":"60","author":"Eickmeier","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26702","article-title":"CD8 T cells primed in the gut-associated lymphoid tissue induce immune-mediated cholangitis in mice","volume":"59","author":"Seidel","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib136","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.26016","article-title":"Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics","volume":"57","author":"Liaskou","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib137","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/gutjnl-2016-312354","article-title":"Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner","volume":"67","author":"Trivedi","year":"2018","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.01.049_bib138","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2009.02.046","article-title":"Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells","volume":"137","author":"Eksteen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.01.049_bib139","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20041035","article-title":"Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1053\/j.gastro.2024.01.049_bib140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jchromb.2011.11.011","article-title":"A\u00a0fluorescent-based HPLC assay for quantification of cysteine and cysteamine adducts in Escherichia coli-derived proteins","volume":"880","author":"Soriano","year":"2012","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1053\/j.gastro.2024.01.049_bib141","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2016.10.003","article-title":"Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis","volume":"77","author":"Chung","year":"2017","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib142","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/hep4.1200","article-title":"Gut and liver B cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease","volume":"2","author":"Chung","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2024.01.049_bib143","article-title":"B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis","volume":"4","author":"Biewenga","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1053\/j.gastro.2024.01.049_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.898615","article-title":"Animal models for autoimmune hepatitis: are current models good enough?","volume":"13","author":"Christen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102897","article-title":"Dual B-cell targeting therapy ameliorates autoimmune cholangitis","volume":"132","author":"Zhang","year":"2022","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib146","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.3390\/cells9122626","article-title":"Function of TREM1 and TREM2 in liver-related diseases","volume":"9","author":"Sun","year":"2020","journal-title":"Cells"},{"key":"10.1053\/j.gastro.2024.01.049_bib147","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jhep.2022.05.044","article-title":"TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation","volume":"77","author":"Labiano","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib148","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2012.11.001","article-title":"Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis","volume":"42","author":"Ehser","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib149","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaut.2010.06.004","article-title":"Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis","volume":"35","author":"Bernuzzi","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib150","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib151","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib152","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib153","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaut.2016.05.005","article-title":"CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease","volume":"72","author":"Liberal","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib154","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhepr.2019.08.001","article-title":"Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis","volume":"1","author":"Oo","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1053\/j.gastro.2024.01.049_bib155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.28517","article-title":"Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis","volume":"64","author":"Chen","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib156","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for IL-2 receptor in regulatory T cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib157","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"Liberal","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib158","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.27884","article-title":"In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression","volume":"62","author":"Liberal","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib159","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2020.06.044","article-title":"Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis","volume":"74","author":"Vuerich","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jhep.2021.03.016","article-title":"Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis","volume":"75","author":"Poch","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib161","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.1800455","article-title":"Bidirectional cross-talk between biliary epithelium and Th17 cells promotes local Th17 expansion and bile duct proliferation in biliary liver diseases","volume":"203","author":"Jeffery","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib162","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/hep.31067","article-title":"The spectrum of reactive cholangiocytes in primary sclerosing cholangitis","volume":"71","author":"Guicciardi","year":"2020","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib163","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.22591","article-title":"Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-\/-) mice","volume":"49","author":"Hsu","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib164","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep4.1202","article-title":"Immune alterations in patients with type 1 autoimmune hepatitis persist upon standard immunosuppressive treatment","volume":"2","author":"Renand","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2024.01.049_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746436","article-title":"Dysfunctional immune regulation in autoimmune hepatitis: from pathogenesis to novel therapies","volume":"12","author":"Vuerich","year":"2021","journal-title":"Front Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib166","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.27840","article-title":"The biliary epithelium presents antigens to and activates natural killer T cells","volume":"62","author":"Schrumpf","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib167","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/hep.29782","article-title":"MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation","volume":"68","author":"B\u00f6ttcher","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib168","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2015.12.017","article-title":"Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1","volume":"64","author":"Jeffery","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib169","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/eji.201847608","article-title":"Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cells","volume":"48","author":"Seth","year":"2018","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ajpath.2021.12.008","article-title":"Bile from patients with primary sclerosing cholangitis contains mucosal-associated invariant T-cell antigens","volume":"192","author":"Valestrand","year":"2022","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2024.01.049_bib171","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"69","author":"Guicciardi","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib172","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jhepr.2019.10.003","article-title":"Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis","volume":"1","author":"Chen","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1053\/j.gastro.2024.01.049_bib173","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hep.31140","article-title":"Monocytes as potential mediators of pathogen-induced T-helper 17 differentiation in patients with primary sclerosing cholangitis (PSC)","volume":"72","author":"Kunzmann","year":"2020","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib174","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188649","article-title":"Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score","volume":"12","author":"Jeffery","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2024.01.049_bib175","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.coi.2013.09.008","article-title":"Natural killer T (NKT) cells in autoimmune hepatitis","volume":"25","author":"Mattner","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib176","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2019.05.023","article-title":"Interferon-\u03b3-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"71","author":"Ravichandran","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib177","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28122","article-title":"Natural killer cells regulate T cell immune responses in primary biliary cirrhosis","volume":"62","author":"Shimoda","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib178","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hep4.1163","article-title":"Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis","volume":"2","author":"Jeffery","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2024.01.049_bib179","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jhep.2012.07.008","article-title":"CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver","volume":"57","author":"Oo","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2249.2001.01391.x","article-title":"Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes","volume":"123","author":"Nishioji","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2024.01.049_bib181","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep4.1170","article-title":"NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid","volume":"2","author":"Graaf","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2024.01.049_bib182","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaut.2010.09.003","article-title":"CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation","volume":"35","author":"Hintermann","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2024.01.049_bib183","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.gastro.2014.04.003","article-title":"Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis","volume":"147","author":"Liaskou","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.01.049_bib184","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1189\/jlb.5A1015-469R","article-title":"CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood","volume":"101","author":"Schoknecht","year":"2017","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1053\/j.gastro.2024.01.049_bib185","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.bbadis.2017.07.026","article-title":"Pathogenesis of biliary fibrosis","volume":"1864","author":"Pinzani","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1053\/j.gastro.2024.01.049_bib186","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/hep.23405","article-title":"Portal fibroblasts: underappreciated mediators of biliary fibrosis","volume":"51","author":"Dranoff","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib187","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/HEP.0000000000000270","article-title":"Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression","volume":"78","author":"Guillot","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib188","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.28274","article-title":"Integrin \u03b1v\u03b26 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis and tumorigenesis","volume":"63","author":"Peng","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib189","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.24613","article-title":"Ductular reactions in human liver: diversity at the interface","volume":"54","author":"Gouw","year":"2011","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib190","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1038\/s41467-022-32575-8","article-title":"Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2024.01.049_bib191","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coph.2021.11.003","article-title":"Emerging drugs for the treatment of primary sclerosing cholangitis","volume":"62","author":"Abbas","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1053\/j.gastro.2024.01.049_bib192","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2023.02.030","article-title":"Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: a coming of age or an age-ist problem?","volume":"79","author":"Ricciuto","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib193","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cld.2022.06.007","article-title":"The inconvenient truth of primary biliary cholangitis\/autoimmune hepatitis overlap syndrome","volume":"26","author":"Hussain","year":"2022","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2024.01.049_bib194","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.01.049_bib195","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib196","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.32773","article-title":"A\u00a0shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation","volume":"77","author":"Hole","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.01.049_bib197","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.01.049_bib198","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2017.06.027","article-title":"Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis","volume":"67","author":"Trivedi","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.01.049_bib199","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","article-title":"The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis","volume":"33","author":"Joshi","year":"2013","journal-title":"Liver International"},{"key":"10.1053\/j.gastro.2024.01.049_bib200","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ibd\/izz325","article-title":"Activity of inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis predicts poorer clinical outcomes","volume":"26","author":"Peverelle","year":"2020","journal-title":"Inflamm Bowel Dis"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524001653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524001653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T17:51:49Z","timestamp":1717523509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508524001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":200,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0016508524001653"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2024.01.049","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2024.01.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the AGA Institute.","name":"copyright","label":"Copyright"}]}}